Details for New Drug Application (NDA): 017262
✉ Email this page to a colleague
The generic ingredient in XENEISOL is xenon xe-133. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.
Summary for 017262
Tradename: | XENEISOL |
Applicant: | Mallinckrodt |
Ingredient: | xenon xe-133 |
Patents: | 0 |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INHALATION, INJECTION | Strength | 18-25mCi/AMP | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription